STOCK MARKET BSE NSE

Zydus Cadila gets USFDA nod for seizure, migraine drug

Drug firm Zydus Cadila today said it has received final approval from the US health regulator to market topiramate extended-release capsules, used for treatment of seizures and migraine.

Published: 27th November 2017 11:59 AM  |   Last Updated: 27th November 2017 11:59 AM   |  A+A-

Image for representational purpose only

By PTI

NEW DELHI: Drug firm Zydus Cadila today said it has received final approval from the US health regulator to market topiramate extended-release capsules, used for treatment of seizures and migraine.

The company has received approval from the US Food and Drug Administration (USFDA) to market the drug in strengths of 25 mg, 50 mg and 100 mg, Zydus Cadila said in a BSE filing. The company said it will manufacture the drug at the group's manufacturing facility at Moraiya, Ahmedabad.

Zydus Cadila has more than 170 approvals and has so far filed over 310 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04. Shares of the company's listed entity Cadila Healthcare were trading 0.55 per cent lower at Rs 443.80 per scrip on BSE.

More from Business.

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp